Physicians' Academy for Cardiovascular Education
Diabetic Kidney Disease: Exploring mechanisms and outcomes of SGLT2 inhibition

Diabetic Kidney Disease: Exploring mechanisms and outcomes of SGLT2 inhibition

CME accredited E-Learning

Online-CME - This course consists of 3 separate lectures

This CME accredited course consists of 3 separate short (12 - 15 minute) lectures. View and complete all 3 items separately and earn 1 CME credit

In this educational programme the role of SGLT2 inhibitors in the management of patients with Diabetic Kidney Disease will be discussed

This course consists of the following 3 lectures

Educational objectives of this course are to:

Expert faculty

Target audience

This educational activity is designed for nephrologists, diabetologists and cardiologists and other healthcare professionals with an interest in treating patients with CKD, Diabetes and CVD

CME accreditation

This online course is accredited by the European Board for Accreditation in Cardiology (EBAC) for 1 hour of external CME credit(s).

Funding

Supported by an unrestricted educational grant received from Boehringer-Ingelheim/Lilly

Online-CME

This is available as accredited online CME for members. Click the button below to enroll:

Enroll
Diabetic Kidney Disease: Exploring mechanisms and outcomes of SGLT2 inhibition

Share this page with your colleagues and friends: